DK1380302T3 - Medikamenter mod retina- og choroidea-sygdomme indeholdende ste-roider som aktiv bestanddel - Google Patents
Medikamenter mod retina- og choroidea-sygdomme indeholdende ste-roider som aktiv bestanddelInfo
- Publication number
- DK1380302T3 DK1380302T3 DK02708676T DK02708676T DK1380302T3 DK 1380302 T3 DK1380302 T3 DK 1380302T3 DK 02708676 T DK02708676 T DK 02708676T DK 02708676 T DK02708676 T DK 02708676T DK 1380302 T3 DK1380302 T3 DK 1380302T3
- Authority
- DK
- Denmark
- Prior art keywords
- active ingredient
- retinal
- medicines
- diseases containing
- containing steroids
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title abstract 4
- 150000003431 steroids Chemical class 0.000 title abstract 4
- 239000003814 drug Substances 0.000 title abstract 3
- 208000017442 Retinal disease Diseases 0.000 title 1
- 208000027129 choroid disease Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 230000002207 retinal effect Effects 0.000 title 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 abstract 2
- 229940124597 therapeutic agent Drugs 0.000 abstract 2
- 229960002537 betamethasone Drugs 0.000 abstract 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 229960000890 hydrocortisone Drugs 0.000 abstract 1
- 230000001976 improved effect Effects 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001092329 | 2001-03-28 | ||
| PCT/JP2002/002950 WO2002078713A1 (fr) | 2001-03-28 | 2002-03-27 | Medicaments contre les affections retiniennes et choroidiennes contenant des steroides comme principe actif |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1380302T3 true DK1380302T3 (da) | 2008-12-08 |
Family
ID=18946808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02708676T DK1380302T3 (da) | 2001-03-28 | 2002-03-27 | Medikamenter mod retina- og choroidea-sygdomme indeholdende ste-roider som aktiv bestanddel |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20040097478A1 (fr) |
| EP (1) | EP1380302B1 (fr) |
| KR (1) | KR100854058B1 (fr) |
| CN (1) | CN100353947C (fr) |
| AT (1) | ATE405274T1 (fr) |
| CA (1) | CA2442296C (fr) |
| CY (1) | CY1108572T1 (fr) |
| DE (1) | DE60228431D1 (fr) |
| DK (1) | DK1380302T3 (fr) |
| ES (1) | ES2311592T3 (fr) |
| PT (1) | PT1380302E (fr) |
| WO (1) | WO2002078713A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005018608A1 (fr) * | 2003-08-20 | 2005-03-03 | Santen Pharmaceutical Co., Ltd. | Systeme d'administration de produit pharmaceutique pour administrer de fins grains sous la capsule de tenon |
| US7374219B2 (en) * | 2004-09-22 | 2008-05-20 | Zephyros, Inc. | Structural reinforcement member and method of use therefor |
| RU2696045C1 (ru) * | 2018-10-15 | 2019-07-30 | Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) | Способ лечения болезни Илза |
| IT201900014052A1 (it) * | 2019-08-05 | 2021-02-05 | Lucia Scorolli | Preparazione para-bulbare con effetto citotrofico-retinico |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4454151A (en) * | 1982-03-22 | 1984-06-12 | Syntex (U.S.A.) Inc. | Use of pyrrolo pyrroles in treatment of ophthalmic diseases |
| JPS61106521A (ja) * | 1984-10-31 | 1986-05-24 | Kureha Chem Ind Co Ltd | 血管増殖抑制剤 |
| ATE162719T1 (de) * | 1989-08-28 | 1998-02-15 | Alcon Lab Inc | Ophthalmische zubereitung |
| US5104787A (en) | 1990-03-05 | 1992-04-14 | Lindstrom Richard L | Method for apparatus for a defined serumfree medical solution useful for corneal preservation |
| KR0185215B1 (ko) * | 1990-11-30 | 1999-05-01 | 요시다 쇼오지 | 서방성 안구삽입용 약제 |
| EP1236470A3 (fr) * | 1991-11-22 | 2004-09-01 | Alcon Laboratories, Inc. | Stéroides angiostatiques |
| WO1993012808A1 (fr) * | 1991-12-20 | 1993-07-08 | Shuji Nakamura | Procede de traitement de la maladie de kaposi et de blocage ou d'inhibition de la permeabilite vasculaire |
| US5770589A (en) * | 1993-07-27 | 1998-06-23 | The University Of Sydney | Treatment of macular degeneration |
| TW420611B (en) * | 1995-03-10 | 2001-02-01 | R Tech Ueno Ltd | Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder |
| JPH11510185A (ja) * | 1995-08-07 | 1999-09-07 | シェーリング コーポレイション | インターロイキン−１０を用いた眼の炎症性状態の処置 |
| ATE493983T1 (de) * | 1996-11-05 | 2011-01-15 | Childrens Medical Center | Thalidomide und dexamethason für die behandlung von tumors |
| US5811446A (en) * | 1997-04-18 | 1998-09-22 | Cytos Pharmaceuticals Llc | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
| US6217895B1 (en) * | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| US6395294B1 (en) * | 2000-01-13 | 2002-05-28 | Gholam A. Peyman | Method of visualization of the vitreous during vitrectomy |
| US6726918B1 (en) * | 2000-07-05 | 2004-04-27 | Oculex Pharmaceuticals, Inc. | Methods for treating inflammation-mediated conditions of the eye |
-
2002
- 2002-03-27 PT PT02708676T patent/PT1380302E/pt unknown
- 2002-03-27 DE DE60228431T patent/DE60228431D1/de not_active Expired - Lifetime
- 2002-03-27 EP EP02708676A patent/EP1380302B1/fr not_active Expired - Lifetime
- 2002-03-27 CN CNB028074858A patent/CN100353947C/zh not_active Expired - Fee Related
- 2002-03-27 DK DK02708676T patent/DK1380302T3/da active
- 2002-03-27 ES ES02708676T patent/ES2311592T3/es not_active Expired - Lifetime
- 2002-03-27 WO PCT/JP2002/002950 patent/WO2002078713A1/fr not_active Ceased
- 2002-03-27 KR KR1020037012670A patent/KR100854058B1/ko not_active Expired - Fee Related
- 2002-03-27 CA CA2442296A patent/CA2442296C/fr not_active Expired - Fee Related
- 2002-03-27 US US10/473,512 patent/US20040097478A1/en not_active Abandoned
- 2002-03-27 AT AT02708676T patent/ATE405274T1/de active
-
2008
- 2008-11-17 CY CY20081101320T patent/CY1108572T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1551775A (zh) | 2004-12-01 |
| EP1380302B1 (fr) | 2008-08-20 |
| CY1108572T1 (el) | 2014-04-09 |
| EP1380302A1 (fr) | 2004-01-14 |
| KR100854058B1 (ko) | 2008-08-26 |
| US20040097478A1 (en) | 2004-05-20 |
| CA2442296C (fr) | 2010-06-22 |
| PT1380302E (pt) | 2008-11-25 |
| ES2311592T3 (es) | 2009-02-16 |
| CA2442296A1 (fr) | 2002-10-10 |
| WO2002078713A1 (fr) | 2002-10-10 |
| ATE405274T1 (de) | 2008-09-15 |
| KR20030087029A (ko) | 2003-11-12 |
| DE60228431D1 (de) | 2008-10-02 |
| EP1380302A4 (fr) | 2006-04-12 |
| CN100353947C (zh) | 2007-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4466973A (en) | Method of treating nasal and sinus congestion | |
| HRP20050781B1 (hr) | Metode i farmaceutske mješavine za pouzdano postizanje prihvatljivih razina testosterona u serumu | |
| EP1064000A4 (fr) | Vitamine d et ses analogues pour le traitement de tumeurs et d'autres troubles d'hyperproliferation | |
| DE69930252D1 (de) | Verwendung von tetracyclinen zur behandlung von störungen der meibomschen drüsen | |
| CA2502437A1 (fr) | Procede et composition contenant du latanoprost destines au traitement de l'hypertension oculaire et d'un glaucome | |
| WO2004105694A3 (fr) | Compositions pharmaceutiques et formes posologiques pour l'administration de medicaments hydrophobes | |
| NO954925D0 (no) | Metode for behandling av smerte ved administrering av 24 timers orale opioidformuleringer som utviser hurtig stigningsgrad av plasmalegemiddelnivå | |
| BRPI0409381A (pt) | formulações farmacêuticas nasais e métodos de utilizar as mesmas | |
| NO925038D0 (no) | Anordning for nedsettelse av medikamentets hudirriterendevirkninger | |
| NO20060200L (no) | Farmasoytisk formulering for prevensjons- og hormonerstatningsterapier | |
| US20060228306A1 (en) | Combination antihistamine and steroid medication | |
| JPH0269413A (ja) | アレルギー性鼻炎の治療方法 | |
| BRPI0409434A (pt) | formulações farmacêuticas nasais e métodos para usar as mesmas | |
| DE60214527D1 (de) | Verwendung von flumazenil bei der entwicklung eines arzneimittels zur behandlung von alkoholabhängigkeit | |
| EP4151210A3 (fr) | Derives de la pyrdine-carboline en tant qu'antagonistes de mchr1 pour leur utilisation en therapie | |
| SE9803761D0 (sv) | Method to avoid increased iridial pigmentation during prostaglandin treatment | |
| YU6196A (sh) | Transdermalna flasterska formulacija | |
| DK1380302T3 (da) | Medikamenter mod retina- og choroidea-sygdomme indeholdende ste-roider som aktiv bestanddel | |
| ATE280578T1 (de) | Kombination von einem den retinoinsäure metabolismus blockierenden arzneimittel und einem tocopherol | |
| DK1343472T3 (da) | Thixotropisk næsespray | |
| TWI713618B (zh) | 外用劑 | |
| DK1492539T3 (da) | Statin-terapi til forögelse af kognitiv funktion | |
| JPH0474135A (ja) | 点眼組成物 | |
| Schaffler et al. | Evaluation of the local anaesthetic activity of dimetindene maleate by means of laser algesimetry in healthy volunteers | |
| DK0654267T3 (da) | Carcinostatisk middel til hormonterapi indeholdende dienogest som aktiv komponent |